Basket | Login | Register


Alzheimer Europe adds new trials to its Clinical Trials Watch

Wednesday 31 July 2019

Alzheimer Europe continues to develop and improve its Clinical Trials Watch (CTW), an innovative online resource providing up-to-date accessible information on clinical trials currently recruiting participants in a least one European country. The service, launched in September 2016, provides information on phase II and III clinical trials that are investigating drugs for the prevention and treatment of dementia and/or Alzheimer’s disease. In July 2019, Alzheimer Europe added three clinical trials to the service, resulting in 9 Phase II and 11 Phase III clinical trials currently reported in the database.

  • LAURIET study (Phase II, Genentech)
  • NorAD (Phase III, Imperial College London)
  • Brexpiprazole study (Phase III, Otsuka)

Further information about the CTW is available on: